Enliven Therapeutics, Inc.
ELVN
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 9 8:12 PM | Collins Helen Louise | Proposed Sale | 45,000 | $29.44 | $1.3M | — | View → |
| Mar 6, 2026 | Mar 6 9:06 PM | Hohl Benjamin | Proposed Sale | 10,000 | $29.29 | $292.9K | — | View → |
| Feb 17, 2026 | Feb 19 11:38 PM | Richard A. HeymanDirector | Sale | 1,230 | $26.18 | $32.2K | 22,647(I) | View → |
| Feb 17, 2026 | Feb 19 11:36 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 45,000 | $26.17 | $1.2M | 25,000(D) | View → |
| Feb 18, 2026 | Feb 18 9:25 PM | Lyssikatos Joseph P | Proposed Sale | 75,000 | $26.13 | $2.0M | — | View → |
| Feb 17, 2026 | Feb 17 9:50 PM | Kintz Samuel | Proposed Sale | 75,000 | $26.72 | $2.0M | — | View → |
| Feb 17, 2026 | Feb 17 9:44 PM | Heyman Richard A. | Proposed Sale | 1,230 | $26.72 | $32.9K | — | View → |
| Feb 17, 2026 | Feb 17 9:40 PM | Collins Helen Louise | Proposed Sale | 45,000 | $26.72 | $1.2M | — | View → |
| Feb 6, 2026 | Feb 10 11:12 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $29.04 | $145.2K | 740,188(I) | View → |
| Feb 2, 2026 | Feb 2 10:38 PM | ANDREW PHILLIPS | Proposed Sale | 21,844 | $28.00 | $611.7K | — | View → |
| Jan 20, 2026 | Jan 22 10:34 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 20,000 | $26.75 | $535.1K | 745,188(I) | View → |
| Jan 20, 2026 | Jan 22 10:33 PM | Richard A. HeymanDirector | Sale | 1,230 | $26.75 | $32.9K | 23,877(I) | View → |
| Jan 20, 2026 | Jan 20 9:55 PM | Heyman Richard A. | Proposed Sale | 1,230 | $26.71 | $32.9K | — | View → |
| Jan 9, 2026 | Jan 9 9:50 PM | Lyssikatos Joseph P | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:49 PM | Kintz Samuel | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:18 PM | Patel Anish | Proposed Sale | 48,300 | $23.25 | $1.1M | — | View → |
| Jan 8, 2026 | Jan 8 9:42 PM | Kintz Samuel | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Lyssikatos Joseph P | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Heyman Richard A. | Proposed Sale | 1,620 | $15.47 | $25.1K | — | View → |
| Jan 8, 2026 | Jan 8 9:18 PM | Heyman Richard A. | Proposed Sale | 12,300 | $15.47 | $190.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Oct 16 8:42 PM | Kristine M BallDirector | Grant/Award | 23,394 | $39.28 | 23,394(D) | View → |
| Oct 1, 2026 | Oct 5 8:57 PM | Scott J. GarlandDirector | Option Exercise | 13,000 | $15.47 | 46,372(D) | View → |
| Sep 17, 2026 | Sep 21 9:23 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Option Exercise | 3,982 | $14.85 | 181,018(D) | View → |
| Sep 17, 2026 | Sep 21 9:22 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 106,268(D) | View → |
| Aug 17, 2026 | Aug 19 8:16 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 111,268(D) | View → |
| Aug 4, 2026 | Aug 7 12:18 AM | Mika K DerynckDirector | Option Exercise | 158,795 | $25.28 | 0(D) | View → |
| Jul 17, 2026 | Jul 21 9:24 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Option Exercise | 1,072 | $2.48 | 84,966(D) | View → |
| Jul 17, 2026 | Jul 21 9:23 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 116,268(D) | View → |
| Jun 17, 2026 | Jun 22 9:13 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Option Exercise | 6,018 | $2.48 | 86,038(D) | View → |
| Jun 17, 2026 | Jun 22 9:11 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 121,268(D) | View → |
| May 18, 2026 | May 20 8:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 126,268(D) | View → |
| Apr 17, 2026 | Apr 22 12:40 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 131,268(D) | View → |
| Mar 25, 2026 | Mar 27 8:57 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $2.48 | 136,268(D) | View → |
| Mar 17, 2026 | Mar 19 9:50 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 176,268(D) | View → |
| Mar 10, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 10,129 | $2.48 | 181,268(D) | View → |
| Mar 9, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 29,871 | $2.48 | 191,397(D) | View → |
| Feb 17, 2026 | Feb 19 11:36 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 45,000 | $2.48 | 221,268(D) | View → |
| Feb 12, 2026 | Feb 18 1:01 AM | Lori Anne KunkelDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 1:00 AM | Richard A. HeymanDirector | Grant/Award | 19,234 | $27.16 | 19,234(D) | View → |
| Feb 12, 2026 | Feb 18 12:59 AM | Rishi GuptaDirector | Grant/Award | 35,569 | $27.16 | 1,580(D) | View → |
Page 1 of 2
Next →